Outcomes and Risk Factor Analysis of Plastic Bronchitis Among 321 Children with Influenza Pneumonia After Bronchoscopy Examination
Qian Hu,Jianle Wu,Chengqian Wang,Wen Liang,Yulei Wang,Yuejie Zheng,Feiqiu Wen,Wenjian Wang,Uet Yu
DOI: https://doi.org/10.2147/IDR.S405444
2023-06-21
Infection and Drug Resistance
Abstract:Qian Hu, 1 Jianle Wu, 1 Chengqian Wang, 1 Wen Liang, 1 Yulei Wang, 1 Yuejie Zheng, 1 Feiqiu Wen, 2 Wenjian Wang, 1, &ast Uet Yu 2, &ast 1 Department of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, People's Republic of China; 2 Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, People's Republic of China &astThese authors contributed equally to this work Correspondence: Uet Yu, Department of Hematology and Oncology, Shenzhen Children's Hospital, 7019, Yitian, Road, Shenzhen, 518038, People's Republic of China, Email Wenjian Wang, Department of Respiratory Diseases, Shenzhen Children's Hospital, 7019, Yitian, Road, Shenzhen, 518038, People's Republic of China, Email Background: Plastic bronchitis (PB) is a rare and severe lung disease. It can be triggered by influenza virus infection, which is a common respiratory infection in children. Bronchoscopy can aid in the early detection and treatment of PB. However, the outcomes and risk for PB development in pediatric patients with influenza virus infection are not fully understood. Methods: Data from 321 children diagnosed with influenza virus pneumonia who underwent bronchoscopy examinations between 1st January, 2009 and 31st December, 2020 were retrospectively analyzed to assess the outcomes and risk factors associated with PB development. Results: This study included 97 girls and 224 boys with influenza virus pneumonia with a median age of 42 months. Among them, 36 patients (11.2%) were categorized as having PB based on bronchoscopy findings. PB patients had significantly longer fever durations ( p =0.010) and higher risks of developing severe conditions including respiratory failure ( p < 0.001), acute respiratory distress syndrome ( p < 0.001), and air-leak syndrome ( p < 0.001) compared to non-PB patients. Conventional treatment including the use of neuraminidase inhibitors and antibiotics did not differ between the PB and non-PB patients, but PB patients required more anti-inflammatory treatment ( p =0.019) and ventilator support ( p < 0.001). Combined univariate and multivariate analyses suggested that radiographic findings, including mediastinal emphysema ( p =0.012) and lung consolidation ( p =0.012), as well as increased levels of neutrophils ( p =0.026), aspartate aminotransferase ( p =0.004), and lactate dehydrogenase ( p < 0.001), were identified as risk factors for PB development in patients with influenza virus pneumonia. Although PB patients required more intensive care and had longer hospital stays, they all recovered well after treatment. Conclusion: Influenza virus infection is linked to PB development in children. Identifying risk factors and early intervention such as bronchoscopy can improve the prognosis of children with PB. Keywords: influenza virus, plastic bronchitis, bronchoscopy, pneumonia, pediatric Plastic bronchitis (PB), also known as cast bronchitis, is a rare lung disease characterized by the formation of thick or gummy casts in the endobronchial system, causing partial or complete airway obstruction, resulting in severe respiratory distress and life-threatening respiratory and circulatory complications. In children, PB can occur at any age but is more prevalent in children aged 2 to 12 years. 1 The number of patients diagnosed with PB has increased in the recent years, probably because there are more and more methods to identify PB such as the use of bronchoscopy. The common symptoms of PB include coughing, wheezing, and shortness of breath. The etiology of PB remains unclear, however, it has been linked to respiratory infections caused by Mycoplasma pneumoniae , influenza virus (Inf-V), adenovirus, and other non-infectious conditions such as lymphatic disorders, congenital heart diseases, severe asthma, cystic fibrosis, sickle cell anemia, and smoking 2–6 in both adults and children. Recent studies have suggested three possible mechanisms for PB development: airway inflammation leading to increased mucus secretion; 7 various infections leading to necrotic detachment of respiratory epithelial cells and mucosal edema; and leakage of lymphatic fluid from the airways. 7–9 However, the exact mechanism and pathophysiology of PB remain unclear. INF-V infection plays an important role in PB pathogenesis. 10 Patients with influenza pneumonia have high morbidity and mortality influenza pneumonia and the severity of pneumonia may be related to PB development. 10–12 A study from Japan identified PB pati -Abstract Truncated-
pharmacology & pharmacy,infectious diseases